A detailed history of Strategy Asset Managers LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Strategy Asset Managers LLC holds 2,157 shares of NVO stock, worth $241,454. This represents 0.06% of its overall portfolio holdings.

Number of Shares
2,157
Previous 4,354 50.46%
Holding current value
$241,454
Previous $559,000 45.08%
% of portfolio
0.06%
Previous 0.12%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 02, 2024

SELL
$122.71 - $146.91 $269,593 - $322,761
-2,197 Reduced 50.46%
2,157 $307,000
Q1 2024

Apr 25, 2024

BUY
$102.11 - $135.92 $4,084 - $5,436
40 Added 0.93%
4,354 $559,000
Q3 2023

Nov 09, 2023

BUY
$90.94 - $199.54 $196,157 - $430,407
2,157 Added 100.0%
4,314 $392,000
Q2 2023

Aug 24, 2023

BUY
$155.98 - $172.65 $336,448 - $372,406
2,157 New
2,157 $349,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $253B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Strategy Asset Managers LLC Portfolio

Follow Strategy Asset Managers LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Strategy Asset Managers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Strategy Asset Managers LLC with notifications on news.